Nasdaq:US$14.22 (+0.06) | HKEX:HK$22.00 (-0.24) | AIM:£2.18 (+0.04)
Search
Announcements
12345678910111213141516
17
18
found Documents: 871
Announcements & Press Releases, Other Ventures | 16 Oct 2009

Newly Published China National Essential Medicines List Reference Prices No Overall Negative Impact on Chi-Med Prices
a091016
Announcements & Press Releases, Other Ventures | 8 Oct 2009

Chi-Med announces joint venture with The Hain Celestial Group to develop natural and organic consumer products in Asia
a091008
Announcements & Press Releases, Other Ventures | 27 Aug 2009

Chi-Med's Main Drugs Included in the New National Essential Medicines List
a090827
Announcements & Press Releases, Group | 30 Jul 2009

Interim Results for the Six Months Ended 30 June 2009
a090730
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004
a090729
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn's Disease Trial for HMPL-004 Delivers Encouraging Results
a090713
Announcements & Press Releases, Regulatory Notice | 8 Jul 2009

Notice of Announcement of 2009 Interim Results
a090708
Announcements & Press Releases, Regulatory Notice | 30 Jun 2009

Blocklisting Six Monthly Return
a090630
Announcements & Press Releases, Regulatory Notice | 8 May 2009

Results of Annual General Meeting
a090508
Announcements & Press Releases, Regulatory Notice | 9 Apr 2009

Director's Shareholding
a090409
Announcements & Press Releases, Regulatory Notice | 6 Apr 2009

2008 Annual Report and Notice of Annual General Meeting
a090406
Announcements & Press Releases, Regulatory Notice | 20 Mar 2009

Date of Annual General Meeting
a090320b
Announcements & Press Releases, Regulatory Notice | 20 Mar 2009

TR-1: Notification of major interests in shares
a090320a
Announcements & Press Releases, Regulatory Notice | 20 Mar 2009

TR-1: Notification of major interests in shares
a090320
Announcements & Press Releases, Group | 16 Mar 2009

Final Results for the year ended 31 December 2008
a090316
Announcements & Press Releases, Regulatory Notice | 2 Mar 2009

TR-1: Notification of major interests in shares
a090302
Announcements & Press Releases, Regulatory Notice | 27 Feb 2009

Notice of Announcement of 2008 Final Results
a090227
Announcements & Press Releases, Oncology / Immunology | 17 Feb 2009

Chi-Med Announces Completion of Patient Enrolment in its US Phase II Crohn's Disease Clinical Trial of HMPL-004, its Lead Anti-Inflammatory Drug Candidate
a090217
Announcements & Press Releases, Regulatory Notice | 22 Jan 2009

TR-1: Notification of major interests in shares
a090122a
Announcements & Press Releases, Regulatory Notice | 22 Jan 2009

TR-1: Notification of major interests in shares
a090122
Announcements & Press Releases, Regulatory Notice | 21 Jan 2009

Holding in Company
a090121
Announcements & Press Releases, Regulatory Notice | 19 Jan 2009

Director's Shareholding
a090119
Announcements & Press Releases, Oncology / Immunology | 8 Jan 2009

HMPL-002 Clinical Update
a090108
Announcements & Press Releases, Regulatory Notice | 30 Dec 2008

Blocklisting Six Monthly Return
a081230
Announcements & Press Releases, Oncology / Immunology | 23 Dec 2008

Hutchison MediPharma Limited Enters into Drug Discovery and Development Partnership With Ortho-McNeil-Janssen Pharmaceuticals, Inc.
a081223
Announcements & Press Releases, Regulatory Notice | 15 Dec 2008

Director's Shareholding
a081215
Announcements & Press Releases, Oncology / Immunology | 21 Nov 2008

Chi-Med Expands Drug Discovery and Development Partnership With Lilly
a081121
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2008

Hutchison MediPharma wins the 2008 American College of Gastroenterology International Award
a081030
Announcements & Press Releases, Regulatory Notice | 8 Oct 2008

Board Change
a081008
Announcements & Press Releases, Group | 6 Aug 2008

Interim Results for the Six Months Ended 30 June 2008
a080806a
Announcements & Press Releases, Regulatory Notice | 6 Aug 2008

Drug R&D Division: New employee share option scheme in Hutchison MediPharma
a080806
Announcements & Press Releases, Regulatory Notice | 18 Jul 2008

Notice of 2008 Interim Results
a080718
Announcements & Press Releases, Regulatory Notice | 30 Jun 2008

Blocklisting Six Monthly Return
a080630
Announcements & Press Releases, Regulatory Notice | 10 Jun 2008

Director's Shareholding
a080610
Announcements & Press Releases, Regulatory Notice | 2 Jun 2008

Board Change
a080602
Announcements & Press Releases, Other Ventures | 23 May 2008

China Healthcare Division Chi-Med increases ownership of its Hutchison Healthcare joint venture
a080523
Announcements & Press Releases, Other Ventures | 19 May 2008

Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
a080519
Announcements & Press Releases, Regulatory Notice | 9 May 2008

Results of Annual General Meeting
a080509
Announcements & Press Releases, Regulatory Notice | 22 Apr 2008

Holding in Company
a080422
Announcements & Press Releases, Regulatory Notice | 9 Apr 2008

Annual Report 2007 and Notice of Annual General Meeting
a080409
Announcements & Press Releases, Regulatory Notice | 31 Mar 2008

Holding in Company
a080331
Announcements & Press Releases, Group | 19 Mar 2008

Preliminary Results for the year ended 31 December 2007
a080319
Announcements & Press Releases, Oncology / Immunology | 29 Feb 2008

Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate
a080229
Announcements & Press Releases, Regulatory Notice | 28 Feb 2008

Change in the Registered Office Address in the Cayman Islands
a080228a
Announcements & Press Releases, Regulatory Notice | 28 Feb 2008

Notice of 2007 Preliminary Results
a080228
Announcements & Press Releases, Other Ventures | 21 Jan 2008

Strong growth in China Healthcare divisionStreamlining of product range set to further improve financial performance
a080121
Announcements & Press Releases, Regulatory Notice | 27 Dec 2007

Block Admission Return
a071227
Announcements & Press Releases, Oncology / Immunology | 22 Nov 2007

Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
a071122
Announcements & Press Releases, Oncology / Immunology | 20 Aug 2007

Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
a070820
Announcements & Press Releases, Group | 9 Aug 2007

Interim Results for the Six Months Ended 30 June 2007
a070809
12345678910111213141516
17
18